Cargando…
Diagnostic delay of myositis: an integrated systematic review
BACKGROUND: Idiopathic inflammatory myopathies (IIM) are a heterogenous group of rare muscular autoimmune diseases characterised by skeletal muscle inflammation with possible diagnostic delay. Our aim was to review the existing evidence to identify overall diagnostic delay for IIM, factors associate...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677896/ https://www.ncbi.nlm.nih.gov/pubmed/36411487 http://dx.doi.org/10.1186/s13023-022-02570-9 |
_version_ | 1784833889975402496 |
---|---|
author | Namsrai, Tergel Parkinson, Anne Chalmers, Anita Lowe, Christine Cook, Matthew Phillips, Christine Desborough, Jane |
author_facet | Namsrai, Tergel Parkinson, Anne Chalmers, Anita Lowe, Christine Cook, Matthew Phillips, Christine Desborough, Jane |
author_sort | Namsrai, Tergel |
collection | PubMed |
description | BACKGROUND: Idiopathic inflammatory myopathies (IIM) are a heterogenous group of rare muscular autoimmune diseases characterised by skeletal muscle inflammation with possible diagnostic delay. Our aim was to review the existing evidence to identify overall diagnostic delay for IIM, factors associated with diagnostic delay, and people’s experiences of diagnostic delay. METHODS: Three databases and grey literature sources were searched. Diagnostic delay was defined as the period between the onset of symptoms and the year of first diagnosis of IIM. We pooled the mean delay using random effects inverse variance meta-analysis and performed subgroup analyses. RESULTS: 328 titles were identified from which 27 studies were included. Overall mean diagnostic delay was 27.91 months (95% CI 15.03–40.79, I(2) = 99%). Subgroup analyses revealed a difference in diagnostic delay between non-inclusion body myositis (IBM) and IBM types. There was no difference in diagnostic delay between studies in which myositis specific autoantibodies (MSA) were tested or not tested. In countries with gatekeeper health systems, where primary care clinicians authorize access to specialty care, people experienced longer periods of diagnostic delay than people with IIM in countries with non-gatekeeper systems. While studies discussed factors that may influence diagnostic delay, significant associations were not identified. No qualitative studies examining people’s experiences of diagnostic delay were identified. CONCLUSION: Diagnostic delay of IIM has extensive impacts on the quality of life of people living with this disease. Understanding the experiences of people with IIM, from symptom onset to diagnosis, and factors that influence diagnostic delay is critical to inform clinical practice and training activities aimed at increasing awareness of this rare disease and expediting diagnosis. Trial registration: PROSPERO Registration number: CRD42022307236 URL of the PROSPERO registration: https://www.crd.york.ac.uk/PROSPEROFILES/307236_PROTOCOL_20220127.pdf SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-022-02570-9. |
format | Online Article Text |
id | pubmed-9677896 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-96778962022-11-22 Diagnostic delay of myositis: an integrated systematic review Namsrai, Tergel Parkinson, Anne Chalmers, Anita Lowe, Christine Cook, Matthew Phillips, Christine Desborough, Jane Orphanet J Rare Dis Review BACKGROUND: Idiopathic inflammatory myopathies (IIM) are a heterogenous group of rare muscular autoimmune diseases characterised by skeletal muscle inflammation with possible diagnostic delay. Our aim was to review the existing evidence to identify overall diagnostic delay for IIM, factors associated with diagnostic delay, and people’s experiences of diagnostic delay. METHODS: Three databases and grey literature sources were searched. Diagnostic delay was defined as the period between the onset of symptoms and the year of first diagnosis of IIM. We pooled the mean delay using random effects inverse variance meta-analysis and performed subgroup analyses. RESULTS: 328 titles were identified from which 27 studies were included. Overall mean diagnostic delay was 27.91 months (95% CI 15.03–40.79, I(2) = 99%). Subgroup analyses revealed a difference in diagnostic delay between non-inclusion body myositis (IBM) and IBM types. There was no difference in diagnostic delay between studies in which myositis specific autoantibodies (MSA) were tested or not tested. In countries with gatekeeper health systems, where primary care clinicians authorize access to specialty care, people experienced longer periods of diagnostic delay than people with IIM in countries with non-gatekeeper systems. While studies discussed factors that may influence diagnostic delay, significant associations were not identified. No qualitative studies examining people’s experiences of diagnostic delay were identified. CONCLUSION: Diagnostic delay of IIM has extensive impacts on the quality of life of people living with this disease. Understanding the experiences of people with IIM, from symptom onset to diagnosis, and factors that influence diagnostic delay is critical to inform clinical practice and training activities aimed at increasing awareness of this rare disease and expediting diagnosis. Trial registration: PROSPERO Registration number: CRD42022307236 URL of the PROSPERO registration: https://www.crd.york.ac.uk/PROSPEROFILES/307236_PROTOCOL_20220127.pdf SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-022-02570-9. BioMed Central 2022-11-21 /pmc/articles/PMC9677896/ /pubmed/36411487 http://dx.doi.org/10.1186/s13023-022-02570-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Review Namsrai, Tergel Parkinson, Anne Chalmers, Anita Lowe, Christine Cook, Matthew Phillips, Christine Desborough, Jane Diagnostic delay of myositis: an integrated systematic review |
title | Diagnostic delay of myositis: an integrated systematic review |
title_full | Diagnostic delay of myositis: an integrated systematic review |
title_fullStr | Diagnostic delay of myositis: an integrated systematic review |
title_full_unstemmed | Diagnostic delay of myositis: an integrated systematic review |
title_short | Diagnostic delay of myositis: an integrated systematic review |
title_sort | diagnostic delay of myositis: an integrated systematic review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677896/ https://www.ncbi.nlm.nih.gov/pubmed/36411487 http://dx.doi.org/10.1186/s13023-022-02570-9 |
work_keys_str_mv | AT namsraitergel diagnosticdelayofmyositisanintegratedsystematicreview AT parkinsonanne diagnosticdelayofmyositisanintegratedsystematicreview AT chalmersanita diagnosticdelayofmyositisanintegratedsystematicreview AT lowechristine diagnosticdelayofmyositisanintegratedsystematicreview AT cookmatthew diagnosticdelayofmyositisanintegratedsystematicreview AT phillipschristine diagnosticdelayofmyositisanintegratedsystematicreview AT desboroughjane diagnosticdelayofmyositisanintegratedsystematicreview |